Skip to content
Clemedi
  • Home
  • Team
  • Tuberculini
  • Awards
  • News
  • Jobs
  • Twitter
  • Facebook
  • LinkedIn

Day: July 15, 2022

Clemedi Update Q2 2022
Jul 15, 2022

Clemedi Update Q2 2022

Dear investors, partners, supporters and friends,we have reached an important milestone and have brought our first product, Tuberculini, to market as a CE-IVD marked medical device. Product Development We have self-certified our product Tuberculini in Germany. It is intended to genotype M. tuberculosis bacteria found in a sample of patients confirmed with tuberculosis. The product…

read more
by Sebastian Dümckein Blog0
  • Twitter
  • Facebook
  • LinkedIn
  • Terms and Conditions
  • Privacy Policy
© 2023 Clemedi. All rights reserved.
  • Twitter
  • Facebook
  • LinkedIn
Address:Wagistr. 12, 8952 Schlieren, Switzerland
Phone:+41 (0)43 229 38 21‬